Engineers Gate Manager’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Sell	66,032 -7,808	-11%	-$187K	0.02%	861
2025 Q4	$1.97M	Buy	73,840 +14,319	+24%	+$342K	0.02%	713
2025 Q3	$1.27M	Buy	59,521 +19,376	+48%	+$458K	0.01%	1026
2025 Q2	$866K	Sell	40,145 -58,759	-59%	-$1.09M	0.01%	1192
2025 Q1	$1.64M	Sell	98,904 -1,044	-1%	-$19K	0.03%	784
2024 Q4	$1.83M	Sell	99,948 -33,246	-25%	-$537K	0.03%	665
2024 Q3	$2.05M	Buy	133,194 +25,449	+24%	+$425K	0.04%	645
2024 Q2	$1.75M	Sell	107,745 -96,928	-47%	-$1.56M	0.04%	616
2024 Q1	$3.78M	Buy	+204,673	New	+$5.07M	0.1%	265
2023 Q4	–	Sell	-142,241	Closed	-$2.96M	–	1935
2023 Q3	$2.96M	Buy	142,241 +76,880	+118%	+$2.09M	0.11%	241
2023 Q2	$1.57M	Sell	65,361 -11,249	-15%	-$250K	0.06%	455
2023 Q1	$1.44M	Buy	76,610 +57,530	+302%	+$1.1M	0.06%	430
2022 Q4	$304K	Sell	19,080 -16,175	-46%	-$253K	0.02%	1179
2022 Q3	$577K	Buy	35,255 +2,568	+8%	+$41.6K	0.04%	705
2022 Q2	$461K	Buy	+32,687	New	+$610K	0.02%	1154
2022 Q1	–	Sell	-24,319	Closed	-$568K	–	1791
2021 Q4	$568K	Buy	+24,319	New	+$489K	0.03%	966
2021 Q3	–	Sell	-11,030	Closed	-$269K	–	1590
2021 Q2	$269K	Sell	11,030 -29,845	-73%	-$674K	0.02%	1204
2021 Q1	$1.05M	Buy	40,875 +32,425	+384%	+$1.43M	0.05%	565
2020 Q4	$452K	Sell	8,450 -41,790	-83%	-$2.07M	0.02%	1040
2020 Q3	$2.07M	Buy	50,240 +33,688	+204%	+$1.45M	0.1%	286
2020 Q2	$802K	Buy	+16,552	New	+$795K	0.04%	699
2020 Q1	–	Sell	-18,151	Closed	-$776K	–	1525
2019 Q4	$776K	Buy	+18,151	New	+$790K	0.03%	775
2019 Q3	–	Sell	-22,550	Closed	-$603K	–	1342
2019 Q2	$603K	Buy	+22,550	New	+$576K	0.03%	658